hrow: the income statement

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Investment loss from eton pharmaceuticals	-	0	-	-
Total other expense, net	-13,727	-6,414	-6,548	-5,521
Income (loss) before income taxes	1,020	4,995	-	-4,200
Income tax expense	-	0	-	20
Net income (loss)	1,020	4,995	-17,780	-4,220

Basic net income (loss) per share of common stock	0.03	0.14	-0.5	-0.12
Diluted net income (loss) per share of common stock	0.03	0.13	-0.5	-0.12
Weighted average number of shares of common stock outstanding, basic	37,145,440	36,790,306	35,826,452	35,702,200
Weighted average number of shares of common stock outstanding, diluted	38,875,005	38,853,855	35,826,452	35,702,200